Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR Takes a Stand: How Position Statements Are Created

Catherine Kolonko  |  Issue: April 2023  |  March 6, 2023

A recent statement about biosimilars, for example, tackled concerns over non-medical switching of prescription drugs. “This is an important issue because cost containment should not be the only focus in the care of patients,” notes Dr. Soloman. “Constant switching from one drug to the next based on cost is a dangerous practice in as much as it can affect the patient’s overall outcome [because] it is not based on clinical indications. The statements always put patient care, the rheumatologist’s expertise and their joint decision-making relationship at the forefront.”

CORC meets regularly to discuss the pros and cons of the issues before it, to identify good practices and policies, and to determine how best to present key points. The committee comprises rheumatologists and interprofessional team members from across the country who routinely treat patients, so they bring broad perspectives to issues considered for position statements, notes Dr. Snow.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The statements always put patient care, the rheumatologist’s expertise & their joint decision-making relationship at the forefront. –Dr. Soloman

“We craft the statement, finalize it and submit it to the ACR Board of Directors for discussion,” he says. “As the CORC chair, I answer questions from the board regarding the statement and why we think it’s needed.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Ultimately, the ACR Board of Directors votes whether to approve the statement. If not approved, it goes back to CORC for additional discussion and possible revision. In some cases, the scope of a statement may shift or expand through this process. The ACR’s newest position statement, on infusions in community rheumatology practices, was initiated in response to member concerns about the practice of white bagging, which limits how physicians can acquire provider-administered drugs. Through discussions, CORC and the Board ultimately developed a broader statement about infusions in a community practice setting.

Statements also evolve over time with changes in science and changes in practice, Dr. Snow says. All are reviewed every four years or sooner if a circumstance arises that requires updates or changes to a position statement.

For some position statements, the review may entail a quick discussion and a few hours to update wording before submitting for board approval. Others may take months to research and debate, craft language and revise before the statement is ready for final review, says Dr. Snow.

Occasionally, CORC moves to retire a position statement, as the committee did recently with a statement on maintenance of certification. This topic had generated a lot of frustration and debate in the past, but those concerns have been addressed and the process is much improved now, says Dr. Snow.

Page: 1 2 3 | Single Page
Share: 

Filed under:American College of RheumatologyLegislation & AdvocacyProfessional Topics Tagged with:ACR advocacyACR position statementsArundathi JayatillekeCommittee on Rheumatologic Care (CORC)Marcus SnowNehad Solomanpolicy

Related Articles

    Committee on Rheumatologic Care Helps Establish Principles & Position Statements

    December 5, 2018

    The ACR’s Committee on Rheumatologic Care (CORC) has been busy on many fronts, including establishing new position statements for the College, introducing new practice perspectives and engaging multiple stakeholders in actions to protect and enhance rheumatology practice, such as with payers. “CORC ensures the rheumatology voice is heard in all of the most critical venues,”…

    Why Community Rheumatologists Serve: Committee Work Pays Off ‘Many Times Over’

    April 16, 2021

    Volunteer leaders who are community rheumatologists share their thoughts about the professional and personal benefits of serving on ACR committees and encourage others to get involved.

    Jennifer Elliott, MD

    The Nebraska Rheumatology Society Grows to Meet State’s Challenges

    May 15, 2020

    As state rheumatology societies go, the Nebraska Rheuma­tology Society (NRS) is one of the new kids on the block. Established two years ago, the NRS hopes to involve all 27 rheumatologists across the state. Marcus Snow, MD, a rheumatologist at the University of Nebraska Medical Center (UNMC), Omaha, says the state’s rheumatologists are spread across…

    Marcus Snow, MD, FACR, Assumes Chair of the Committee on Rheumatologic Care

    December 16, 2020

    Marcus Snow, MD, FACR, had his first exposure to rheumatology in a rotation during his residency at the University of Nebraska Medical Center, Omaha. James O’Dell, MD, Theodore Mikuls, MD, Jay Moore, MD, Lynn Klassen, MD, and other physicians showed how rheumatology could be the perfect mix of a narrow clinical focus with interesting patient…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences